9PUY | pdb_00009puy

SARS-CoV-2 Papain-like Protease (PLpro) in complex with Fragment 27


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.75 Å
  • R-Value Free: 
    0.205 (Depositor), 0.204 (DCC) 
  • R-Value Work: 
    0.171 (Depositor), 0.171 (DCC) 
  • R-Value Observed: 
    0.172 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9PUY

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Discovery of Fragment-Based Inhibitors of SARS-CoV-2 PL Pro .

Wei, Q.Taylor, A.J.Barmade, M.A.Teuscher, K.B.Chowdhury, S.Apakama, C.Anderson-Daniels, J.Yongqing, Z.Schultz, D.C.Rietz, T.A.South, T.M.Crow, M.M.Zhao, B.Amporndanai, K.Sensintaffar, J.L.Phan, J.Cherry, S.Denison, M.Lee, T.Fesik, S.W.

(2026) J Med Chem 69: 1419-1433

  • DOI: https://doi.org/10.1021/acs.jmedchem.5c02832
  • Primary Citation Related Structures: 
    9PUH, 9PUJ, 9PUY, 9PV6, 9PV9, 9PVI, 9PVK

  • PubMed Abstract: 

    SARS-CoV-2 papain-like protease (PL Pro ) plays a key role in viral replication and the host immune response and is a promising target for developing new antiviral treatments. We previously reported a fragment-based screen to identify hits that bind to SARS-CoV-2 PL Pro . Here, we describe the discovery of potent PL Pro inhibitors by optimizing one of these hits via extensive medicinal chemistry guided by multiple X-ray structures of cocomplexes. Lead compound 46 is shown to bind to the S3 and S4 pockets with nanomolar affinity (0.4 μM) and exhibits robust cellular activity and resistance to mutation. This novel class of PL Pro inhibitors can potentially be used as a starting point for the development of inhibitors to combat the emergence of drug-resistant viral strains and future coronavirus outbreaks.


  • Organizational Affiliation
    • Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States.

Macromolecule Content 

  • Total Structure Weight: 150.66 kDa 
  • Atom Count: 11,722 
  • Modeled Residue Count: 1,275 
  • Deposited Residue Count: 1,304 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Papain-like protease nsp3
A, B, C, D
326Severe acute respiratory syndrome coronavirus 2Mutation(s): 1 
Gene Names: rep1a-1b
EC: 3.4.19.12 (PDB Primary Data), 3.4.22 (PDB Primary Data)
UniProt
Find proteins for P0DTD1 (Severe acute respiratory syndrome coronavirus 2)
Explore P0DTD1 
Go to UniProtKB:  P0DTD1
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0DTD1
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1CLD
(Subject of Investigation/LOI)

Query on A1CLD



Download:Ideal Coordinates CCD File
F [auth A],
J [auth B],
P [auth C],
S [auth D]
7,8-dimethyl-1'-[(pyridin-2-yl)methyl]spiro[[1]benzopyran-2,4'-piperidin]-4(3H)-one
C21 H24 N2 O2
ZJGZEFXFZOGTNZ-UHFFFAOYSA-N
PO4

Query on PO4



Download:Ideal Coordinates CCD File
G [auth A],
K [auth B],
L [auth B],
T [auth D],
U [auth D]
PHOSPHATE ION
O4 P
NBIIXXVUZAFLBC-UHFFFAOYSA-K
ZN

Query on ZN



Download:Ideal Coordinates CCD File
E [auth A],
I [auth B],
O [auth C],
R [auth D]
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
K

Query on K



Download:Ideal Coordinates CCD File
H [auth A],
M [auth B],
N [auth B],
Q [auth C],
V [auth D]
POTASSIUM ION
K
NPYPAHLBTDXSSS-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.75 Å
  • R-Value Free:  0.205 (Depositor), 0.204 (DCC) 
  • R-Value Work:  0.171 (Depositor), 0.171 (DCC) 
  • R-Value Observed: 0.172 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 98.269α = 90
b = 118.978β = 90
c = 124.824γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
PHENIXrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesU19AI171292

Revision History  (Full details and data files)

  • Version 1.0: 2026-01-21
    Type: Initial release
  • Version 1.1: 2026-02-04
    Changes: Database references